Aethlon Medical (AEMD) Non Operating Investment Income (2022)

Aethlon Medical (AEMD) posted Non Operating Investment Income of -$142121.0 for Q3 2022.

Aethlon Medical (AEMD) Non Operating Investment Income (2022) Analysis & Trends

Aethlon Medical's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at -$142121.0 for Q3 2022.

  • Quarterly Non Operating Investment Income changed N/A year-over-year to -$142121.0 in Q3 2022, while the trailing twelve-month figure through Sep 2023 was -$142121.0 (changed 0.0% YoY) and the FY2023 annual result came in at -$142121.0, changed N/A from the prior year.
  • Non Operating Investment Income was -$142121.0 for Q3 2022 at Aethlon Medical.
  • Across five years, Non Operating Investment Income topped out at -$142121.0 in Q3 2022 and bottomed at -$142121.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 183.64 Bn 176.34 Bn 6.27 Bn -
2 Stryker 129.04 Bn 126.16 Bn 3.81 Bn -
3 Medtronic 109.04 Bn 99.82 Bn 6.41 Bn -
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn -
5 Edwards Lifesciences 48.67 Bn 45.00 Bn 1.29 Bn -
6 Dexcom 28.40 Bn 27.28 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.37 Bn 26.08 Bn 1.98 Bn -
8 Smith & Nephew 26.92 Bn 26.34 Bn - -
9 Koninklijke Philips 25.48 Bn 22.36 Bn 2.07 Bn -
10 Aethlon Medical 384,216.05 384,216.05 - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -142,121.00
Sep 30, 2022 -142,121.00